Literature DB >> 1413377

Marijuana use and the risk of new onset seizures.

J C Brust1, S K Ng, A W Hauser, M Susser.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1413377      PMCID: PMC2376682     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN: 0065-7778


× No keyword cloud information.
  33 in total

1.  Clinical competence and research.

Authors: 
Journal:  Lancet       Date:  1980-03-22       Impact factor: 79.321

2.  Letter: The effect of cannabidiol on maximal electroshock seizures in rats.

Authors:  I Izquierdo; M Tannhauser
Journal:  J Pharm Pharmacol       Date:  1973-11       Impact factor: 3.765

3.  The influence of cannabidiol and delta 9-tetrahydrocannabinol on cobalt epilepsy in rats.

Authors:  P Chiu; D M Olsen; H K Borys; R Karler; S A Turkanis
Journal:  Epilepsia       Date:  1979-08       Impact factor: 5.864

4.  Use of a potential rabbit model for structure--behavioral activity studies of cannabinoids.

Authors:  P Consroe; A R Martin; B S Fish
Journal:  J Med Chem       Date:  1982-05       Impact factor: 7.446

5.  Effects of marihuana cannabinoids on seizure activity in cobalt-epileptic rats.

Authors:  B K Colasanti; C Lindamood; C R Craig
Journal:  Pharmacol Biochem Behav       Date:  1982-04       Impact factor: 3.533

6.  Levonantradol potentiates the anticonvulsant effects of diazepam and valproic acid in the kindling model of epilepsy.

Authors:  C L Ehlers; S J Henriksen; F E Bloom
Journal:  J Clin Pharmacol       Date:  1981 Aug-Sep       Impact factor: 3.126

7.  Electrophysiologic properties of the cannabinoids.

Authors:  S A Turkanis; R Karler
Journal:  J Clin Pharmacol       Date:  1981 Aug-Sep       Impact factor: 3.126

8.  Chronic administration of cannabidiol to healthy volunteers and epileptic patients.

Authors:  J M Cunha; E A Carlini; A E Pereira; O L Ramos; C Pimentel; R Gagliardi; W L Sanvito; N Lander; R Mechoulam
Journal:  Pharmacology       Date:  1980       Impact factor: 2.547

9.  Subacute cannabinoid treatment: anticonvulsant activity and withdrawal excitability in mice.

Authors:  R Karler; S A Turkanis
Journal:  Br J Pharmacol       Date:  1980-03       Impact factor: 8.739

10.  Inheritance of delta 9-tetrahydrocannabinol seizure susceptibility in rabbits.

Authors:  B S Fish; P Consroe; R R Fox
Journal:  J Hered       Date:  1981 May-Jun       Impact factor: 2.645

View more
  11 in total

Review 1.  Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.

Authors:  Orrin Devinsky; Maria Roberta Cilio; Helen Cross; Javier Fernandez-Ruiz; Jacqueline French; Charlotte Hill; Russell Katz; Vincenzo Di Marzo; Didier Jutras-Aswad; William George Notcutt; Jose Martinez-Orgado; Philip J Robson; Brian G Rohrback; Elizabeth Thiele; Benjamin Whalley; Daniel Friedman
Journal:  Epilepsia       Date:  2014-05-22       Impact factor: 5.864

2.  Medical Marijuana for Epilepsy?

Authors:  Murali K Kolikonda; Kavitha Srinivasan; Manasa Enja; Vishwanath Sagi; Steven Lippmann
Journal:  Innov Clin Neurosci       Date:  2016-04-01

3.  Slim evidence for cannabinoids for epilepsy.

Authors:  John W Miller
Journal:  Epilepsy Curr       Date:  2013-03       Impact factor: 7.500

4.  Cannabidiol: promise and pitfalls.

Authors:  Timothy E Welty; Adrienne Luebke; Barry E Gidal
Journal:  Epilepsy Curr       Date:  2014-09       Impact factor: 7.500

Review 5.  The Potential Proconvulsant Effects of Cannabis: a Scoping Review.

Authors:  Eric E Kaczor; Kevin Greene; Jennifer Zacharia; Laura Tormoehlen; Mark Neavyn; Stephanie Carreiro
Journal:  J Med Toxicol       Date:  2022-03-29

Review 6.  Cannabinoids and Epilepsy.

Authors:  Evan C Rosenberg; Richard W Tsien; Benjamin J Whalley; Orrin Devinsky
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

Review 7.  Cannabinoids for epilepsy.

Authors:  David Gloss; Barbara Vickrey
Journal:  Cochrane Database Syst Rev       Date:  2014-03-05

8.  Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis.

Authors:  Robin M Murray; Harriet Quigley; Diego Quattrone; Amir Englund; Marta Di Forti
Journal:  World Psychiatry       Date:  2016-10       Impact factor: 49.548

Review 9.  Do Cannabinoids Confer Neuroprotection Against Epilepsy? An Overview.

Authors:  Anna Capasso
Journal:  Open Neurol J       Date:  2017-12-18

Review 10.  Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?

Authors:  Emilio Perucca
Journal:  J Epilepsy Res       Date:  2017-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.